Companies / CYV

CERYVYN THERAPEUTICS LIMITED

ASX:CYVPharmaceuticals, Biotechnology & Life Sciences
1.37B shares on issueASX (delayed) · snapshot 11 Sept 20261.55B fully diluted+13.7% if every option and right converts$0.011price · delayed$15.0Mmarket cap · indicative

Today’s holders own 88.0% of what they think they own, once every option and right converts.

Minimal
Dilution riskprovisional — limited history

Options/rights overhang 14% of shares; proposed issue pending; since relisting as CYV; prior history under OPT not included

MinimalVery high
Absolute levels — not a ranking against other companies.
Cash runway25.9 quarters of funding
Share-count growth (24m)0.0%no issuance filings since 2024; since relisting as CYV; prior history under OPT not included
Raise cadence (24m)0 cash raisessince relisting as CYV; prior history under OPT not included
Options & rights overhang13.7% of shares
In-the-money supplyno data — an exercise price is on record for a minority of the supply
Pending proposed issuesopen proposed issue (Appendix 3B)

CERYVYN THERAPEUTICS LIMITED does not have any share-issuance filings on record since January 2024. The company has not raised capital in the past 24 months. Options and rights on issue could convert into 187M new shares, representing 13.7% of the current share count, with no options currently in the money; the nearest expiry date for these options is August 2031. As of June 2026, the company held A$29.1M in available cash, which would cover 25.9 quarters of its recent spending. Two proposed securities issues (Appendix 3B) are pending, with the nearest proposed date in September 2026.

AI-generated summary of this page's cited filings · updated 11 Sept 2026
Get told when this changes
Set up alerts
Daily email alerts cover risk-level moves, new raises, pending proposed issues and option expiries for the companies you follow.
13.7%
Options & rights overhang
In-the-money supply · most strikes not on record
0
Raises · last 12 months
25.9 qtrs
Cash cover · over 4 quarters

Shares on issue — last 2 years

Ordinary shares on issue
Weekly counts from ASX records. Dots mark cash capital raises. Shown since relisting as CYV (6 July 2026); prior history under OPT is not included. Latest count 1.37B per ASX (delayed) (snapshot 11 Sept 2026).
1.360B1.365B1.370B1.375BJuly 26Aug 26Sept 261.37B

Cash runway

25.9 qtrs
More than four quarters of funding at the recent spend rate.
More than three years of funding at the reported spend rate — far enough out that a dated estimate would be false precision.
$29.1M cash after burn from the quarter ended 30 June 2026 · Runway is computed from Appendix 4C/5B filings and announced raise proceeds. Filed with the quarterly report: $30.0M cash at quarter end (item 4.6), 26.8 qtrs of funding on the company’s own estimate. Our figure above carries the filed quarter-end balance forward at the reported spend rate and adds announced raise proceeds.
Free account
1 quarter on record — Cash runway history
Quarterly cash, net spend and cover trend from every Appendix 4C/5B on record up to 30 June 2026.
Free account: 2 full company unlocks every month, no card.
Create free accountSee plans

Issuance timeline

Latest 2 filings (Appendix 2A quoted issues, 3G unquoted, 3H cancellations)

DateFormSecurityOn issue, per this filingSource
21 Aug 20263G · unquotedCYV : ORDINARY FULLY PAID1.37BAppendix 3G
13 July 20263H · cancellationCYV : ORDINARY FULLY PAID1.37BAppendix 3H
Free account
2 filings on record — Full issuance history
Every quoted and unquoted issue and cancellation on record, plus unquoted securities (Appendix 4.2).
Free account: 2 full company unlocks every month, no card.
Create free accountSee plans

Capital raises

No equity raises on record since relisting as CYV (6 July 2026); prior history under OPT is not included.
Free account
4 raises on record — Full raise history
Issue price, shares issued, brokers and stated purpose for every raise on record.
Free account: 2 full company unlocks every month, no card.
Create free accountSee plans

Forward supply

Every dated event on record that could add securities to the register — option expiries to their stated dates and proposed issues over the next 18 months, on one timeline.

Free account
4 dated events on record — Forward supply calendar
Option expiries and proposed issues on one forward timeline, with the securities each could add.
Free account: 2 full company unlocks every month, no card.
Create free accountSee plans

Placement capacity

How much stock a company can place without asking holders. Listing Rule 7.1 allows 15% of ordinary securities in any 12 months, and every Appendix 3B states how much of it an issue uses.

No estimateno share count old enough to measure 15% of.
Free account
Placement capacity — LR 7.1 / 7.1A
The filings behind the figure: every Appendix 3B in the window with what it says was issued under 7.1 and 7.1A, each row linked to its filing, and how many shares are left.
Free account: 2 full company unlocks every month, no card.
Create free accountSee plans

Pending proposed issues

1 proposed issue pending — Appendix 3B lodged, securities not yet issued. New shares from these issues are not in the counts above until quoted.
Paid plan
1 pending issue on record — Pending issue detail
Size, price, fees, broker and placement-capacity usage for each pending issue.
Unlocks on a paid plan
See plans

Options & convertible securities

13.7%
Options & rights overhang · of current shares
In-the-money supply · most strikes not on record
187.0M
Potential new shares
Aug 2031
Nearest expiry
What this supply is, and what converts it
  • Price-triggered172.4M · 12.6% of shares
    Options and warrants — they convert when the share price clears their exercise price.
    At least 164.9M of it states no exercise price — that much cannot be called in or out of the money.
  • Condition-triggered2.9M · 0.2% of shares
    Performance and incentive rights — they convert when a hurdle is met, not at a price, and can lapse to nothing.
  • Not classified11.7M · 0.9% of shares
    The filing’s description does not identify the instrument.

Exercise price on record: 7.5M priced, 179.5M where the filing never states one. A security with no exercise price is never counted in the money — nothing is paid to convert it, so there is no price for it to be above.

Each figure is the filing’s own count of securities, not a share count — a 2A never states what one security converts into.

What a price move would switch on
93.5M187.0M$0.011 now0.25× today ($0.003) — 0 of the priced supply in the money, 0.0% of shares on issue0.5× today ($0.005) — 0 of the priced supply in the money, 0.0% of shares on issue0.75× today ($0.008) — 0 of the priced supply in the money, 0.0% of shares on issue1× today ($0.011) — 0 of the priced supply in the money, 0.0% of shares on issue1.25× today ($0.014) — 7.2M of the priced supply in the money, 0.5% of shares on issue1.5× today ($0.017) — 7.2M of the priced supply in the money, 0.5% of shares on issue2× today ($0.022) — 7.2M of the priced supply in the money, 0.5% of shares on issue3× today ($0.033) — 7.2M of the priced supply in the money, 0.5% of shares on issue5× today ($0.055) — 7.2M of the priced supply in the money, 0.5% of shares on issue10× today ($0.110) — 7.2M of the priced supply in the money, 0.5% of shares on issue0.25×0.5×0.75×now1.25×1.5×10×

An exercise price is on record for only 4.0% of this supply, so what is in the money today is not a measurement — the tile above reads “—” for that reason. Of the priced supply, 0 is in the money at $0.011 today. No more priced supply until 1.25× today’s price, which takes it to 7.2M (0.5% of shares).

  • Priced supply in the money at the price on the axis — the curve, and the only thing on it. Ten prices, sampled: between two of them the true figure lies between the two.
  • 179.5M (96.0% of the supply above) states no exercise price at all. It cannot be called in or out of the money at any price, which is why it is hatched rather than plotted.
  • 277k more carries an exercise price above ten times today’s — off the right of this axis, and in every total on this page.
CodeSecurityTypeExercise priceExpiryOn issueSource
OptionsPrice-triggered$0.01120 Aug 20317.2MFiling
CYVALOptionsPrice-triggered$3.0319 Feb 2034250kFiling
CYVAAOptionsPrice-triggered$4.1431 Mar 203427kFiling
CYVADPerformance rightsCondition-triggered2.9MFiling
CYVACNot classified11.7MFiling
CYVABOptionsPrice-triggered164.9MFiling

“Nil” is a stated nil exercise price: nothing is paid to convert. An em dash means the filing names no exercise price at all. Security is read from the filing’s own class description; an em dash there means the description is not one this table labels. One row is one security class, at the number stated in the most recent quotation application that restated it — linked, and dated, in the last column.

Free account
6 option lines on record — In-the-money value & price ladder
What each line is worth in the money today, the price ladder to the next tranche that converts, and the filing description behind every code.
Free account: 2 full company unlocks every month, no card.
Create free accountSee plans

Director dealings

No director dealing notices (Appendix 3Y) on record.
Free account
Full dealing history
Every change-of-director's-interest notice on record, with direction and consideration.
Free account: 2 full company unlocks every month, no card.
Create free accountSee plans

Ownership

Free account
Top-20 holders & substantial holder notices
Top-20 register snapshot and substantial-holder movements, each linked to its source notice.
Free account: 2 full company unlocks every month, no card.
Create free account

Latest announcements

Headlines link to the source PDFs on the ASX announcements platform. Data as of 12 Sept 2026.